Gemcitabine/Oxaliplatin and Photodynamic Therapy in Cholangiocarcinoma
Status:
Withdrawn
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
In patients with cholangiocarcinoma therapeutic effects have been reported for
Gemcitabine/Oxaliplatin. Furthermore, photodynamic therapy (PDT) has significantly improved
patients survival in two randomised trials. PDT induces tumor necrosis only in an area of few
millimetres, while tumor parts which are located beyond this area remain untreated. An
additive effect could result from PDT as a local therapy in combination with systemic
chemotherapy.